Compare CORT & KRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | KRC |
|---|---|---|
| Founded | 1998 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.1B |
| IPO Year | N/A | 1997 |
| Metric | CORT | KRC |
|---|---|---|
| Price | $39.83 | $31.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 14 |
| Target Price | ★ $114.20 | $40.46 |
| AVG Volume (30 Days) | 1.9M | ★ 2.2M |
| Earning Date | 02-18-2026 | 02-09-2026 |
| Dividend Yield | N/A | ★ 6.80% |
| EPS Growth | N/A | ★ 31.07 |
| EPS | 0.87 | ★ 2.32 |
| Revenue | $741,172,000.00 | ★ $1,112,667,000.00 |
| Revenue This Year | $23.09 | $3.62 |
| Revenue Next Year | $29.62 | N/A |
| P/E Ratio | $45.76 | ★ $13.69 |
| Revenue Growth | ★ 17.92 | N/A |
| 52 Week Low | $32.99 | $27.07 |
| 52 Week High | $117.33 | $45.03 |
| Indicator | CORT | KRC |
|---|---|---|
| Relative Strength Index (RSI) | 38.81 | 18.94 |
| Support Level | $38.00 | $30.00 |
| Resistance Level | $41.92 | $35.06 |
| Average True Range (ATR) | 2.02 | 0.93 |
| MACD | 0.93 | -0.32 |
| Stochastic Oscillator | 24.95 | 9.69 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
Kilroy Realty is a premier owner and landlord of approximately 17 million square feet of office space across Los Angeles, San Diego, the San Francisco Bay Area, Austin, Texas, and greater Seattle. The company operates as a real estate investment trust.